Xing M. Zhong

No. 678 Furong Road
Hefei, 230061, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Glucagon-like peptide-1 receptor agonist dulaglutide attenuates liver injury in metabolic dysfunction-associated steatotic liver disease with diabetic mice.

Glucagon-like peptide-1 receptor agonist dulaglutide attenuates liver injury in metabolic dysfunction-associated steatotic liver disease with diabetic mice.

Journal: European journal of pharmacology

Published: March 16, 2026

Association analysis and exploratory mediation study of the stress-induced hyperglycaemia ratio and glycaemic ratio indices with diabetic retinopathy in patients with type 2 diabetes.

Association analysis and exploratory mediation study of the stress-induced hyperglycaemia ratio and glycaemic ratio indices with diabetic retinopathy in patients with type 2 diabetes.

Journal: Frontiers in nutrition

Published: January 28, 2026

Association between thyroid dysfunction and cognitive impairment in type 2 diabetes mellitus: A cross-sectional study.

Association between thyroid dysfunction and cognitive impairment in type 2 diabetes mellitus: A cross-sectional study.

Journal: Journal of diabetes investigation

Published: January 26, 2026

Distinguishing Insulinoma From Reactive Hypoglycemia: Characteristic Glycemia Patterns During the 5-Hour Oral Glucose Tolerance Test.

Distinguishing Insulinoma From Reactive Hypoglycemia: Characteristic Glycemia Patterns During the 5-Hour Oral Glucose Tolerance Test.

Journal: AACE endocrinology and diabetes

Published: November 08, 2025

Identification and validation of ferroptosis-related genes for diabetic nephropathy.

Identification and validation of ferroptosis-related genes for diabetic nephropathy.

Journal: European journal of pharmacology

Published: October 22, 2025

FAR1 as a ferroptosis-related biomarker and potential therapeutic target in acute kidney injury: integrated bioinformatics and experimental validation.

FAR1 as a ferroptosis-related biomarker and potential therapeutic target in acute kidney injury: integrated bioinformatics and experimental validation.

Journal: Renal failure

Published: August 19, 2025

Association between Zhejiang University index and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.

Association between Zhejiang University index and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.

Journal: World journal of diabetes

Published: June 05, 2025

Author Correction: High-resolution fundus images for ophthalmomics and early cardiovascular disease prediction.

Author Correction: High-resolution fundus images for ophthalmomics and early cardiovascular disease prediction.

Journal: Scientific data

Published: April 25, 2025

The research of dapagliflozin on cognitive function in middle-aged and older patients with type 2 diabetes mellitus and mild cognitive impairment: a 36-week prospective parallel control study.

The research of dapagliflozin on cognitive function in middle-aged and older patients with type 2 diabetes mellitus and mild cognitive impairment: a 36-week prospective parallel control study.

Journal: European journal of pharmacology

Published: March 26, 2025

Relationship between triglyceride-glucose index and muscle strength in middle-aged and older Chinese adults without chronic diseases: a nationwide longitudinal cohort study.

Relationship between triglyceride-glucose index and muscle strength in middle-aged and older Chinese adults without chronic diseases: a nationwide longitudinal cohort study.

Journal: Scientific reports

Published: January 15, 2025

High-resolution fundus images for ophthalmomics and early cardiovascular disease prediction.

High-resolution fundus images for ophthalmomics and early cardiovascular disease prediction.

Journal: Scientific data

Published: December 27, 2024

Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis.

Dapagliflozin attenuates metabolic dysfunction-associated steatotic liver disease by inhibiting lipid accumulation, inflammation and liver fibrosis.

Journal: BMC pharmacology & toxicology

Published: December 15, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026